David M. Goldstein
Direttore Tecnico/Scientifico/R&S presso PRINCIPIA BIOPHARMA INC.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Martin Babler | M | 59 |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | 13 anni |
| Severin Schwan | M | 57 | 16 anni | |
| Alan Colowick | M | 61 |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | 6 anni |
| Chris Varma | M | - |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | 6 anni |
| Othman Laraki | M | 46 |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | - |
| Thomas Schinecker | M | 49 | 21 anni | |
| Roberto Zoncu | M | - |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | 6 anni |
| Zheng Bin Yao | M | 58 |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | 3 anni |
| Daniel K. Nomura | M | - |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | 6 anni |
| André S. Hoffmann | M | 66 | 28 anni | |
| Betsy Santos | F | - | - | |
| James Tananbaum | M | 60 |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | 3 anni |
| John Schroer | M | 58 |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | 2 anni |
| Setareh Pouraghabagher | F | 53 |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | 2 anni |
| Luke Evnin | M | 60 |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | - |
| Cameron Wheeler | M | 45 |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | - |
| Janwillem Naesens | M | 41 |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | - |
| Pamela Klein | M | 63 |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | 1 anni |
| Paul Laland | M | - | - | |
| Sapna R. Srivastava | M | 53 |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | 2 anni |
| John Reed | M | 65 | - | |
| Joan S Brugge | M | - |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| DeAnne Shirley Julius | M | 75 | 14 anni | |
| Andreas Oeri | M | 75 | 24 anni | |
| Erich Hunziker | M | 70 | 10 anni | |
| Walter Frey | M | 81 | 10 anni | |
| John Bell | M | 72 | 19 anni | |
| Lodewijk J. R. de Vink | M | 78 | 9 anni | |
| Christopher Chai | M | 58 | 7 anni | |
| June Lee | M | 58 |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | - |
| Bruno Gehrig | M | 77 | 9 anni | |
| Domenico Scala | M | 59 | 8 anni | |
| Horst Teltschik | M | 84 | - | |
| Wolfgang Ruttenstorfer | M | 73 | 4 anni | |
| Christoph Franz | M | 64 | 12 anni | |
| Simeon George | M | 47 | 9 anni | |
| Pius Baschera | M | 73 | 10 anni | |
| Peter Thompson | M | 64 | 8 anni | |
| Roy Hardiman | M | 64 | 5 anni | |
| Beatrice Weder di Mauro | M | 57 | 10 anni | |
| Henri-Paul Meier | M | - | - | |
| John Smither | M | 71 | - | |
| Dan Becker | M | 49 | 3 anni | |
| Clive Meanwell | M | 67 | 9 anni | |
| Arthur Levinson | M | 73 | - | |
| William Burns | M | 76 | 4 anni | |
| Paul Bulcke | M | 69 | 11 anni | |
| Klaus Gustav Strein | M | - | 13 anni | |
| Vincent Charlon | M | - | 8 anni | |
| Steve Krognes | M | 55 | 5 anni | |
| Jean-Jacques Garaud | M | 69 | 5 anni | |
| Unni Hjelmaas | F | - | 3 anni | |
| Michael Burgess | M | 61 | - | |
| David Kabakoff | M | 76 | 2 anni | |
| Torsten Hoffmann | M | 57 | 16 anni | |
| Greg S. Yap | M | - | 3 anni | |
| Shawn Tomasello | F | 65 | 1 anni | |
| Michael Mulqueen | M | - | 13 anni | |
| Michael Byrnes | M | 47 | - | |
| Olivia Ware | F | 67 | 2 anni | |
| Luca Santarelli | M | 55 | 8 anni | |
| Shao Lee Lin | M | 57 | 1 anni | |
| Christopher Vann | M | 59 | 22 anni | |
| Stefani Wolff | F | 62 | 4 anni | |
| Dolca Thomas | M | 53 | 2 anni | |
| Marc M. Gibeley | M | 59 | 5 anni | |
| Anton Affentranger | M | 68 | - | |
| Dirk W. Kirsten | M | 56 | 2 anni | |
| Bradley Bolzon | M | 64 | 4 anni | |
| Gerald Heinz Möller | M | 80 | - | |
| Peter Brabeck-Letmathe | M | 79 | 10 anni | |
| Clarence Machado | M | 60 | 1 anni | |
| Lewis J. Shuster | M | 68 | - | |
| Stephen Hill | M | 65 | 2 anni | |
| Hany Massarany | M | 62 | 2 anni | |
| Franz Humer | M | 77 | 19 anni | |
| Richard Scheller | M | 70 | 5 anni | |
| Rolf Hänggi | M | 81 | 10 anni | |
| Per-Olof Attinger | M | 64 | - | |
| Eduard Enrico Holdener | M | 79 | 12 anni | |
| Rolf Schläpfer | M | 68 | - | |
| Julian Baker | M | 57 |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | - |
| Phyllis Whiteley | M | - | 5 anni | |
| Jürg Witmer | M | 76 | 21 anni | |
| Myriam Meyer Stutz | M | 62 | 3 anni | |
| Steven Gourlay | M | 64 | 5 anni | |
| Michael Dybbs | M | 49 | 2 anni | |
| Mohammad Masjedizadeh | M | - | 5 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 88 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- David M. Goldstein
- Contatti personali
